Literature DB >> 404369

Pharmacokinetics of methicillin in patients with cystic fibrosis.

S J Yaffe, L M Gerbracht, L L Mosovich, M E Mattar, M Danish, W J Jusko.   

Abstract

The disposition of methicillin in normal subjects and in subjects with cystic fibrosis (CF) was studied after administration of single intravenous doses of 15 mg/kg. The area under the serum concentration vs. time curve for CF patients was, on the average, only 75% of that found for normal subjects. The low concentrations in serum were caused by more rapid urinary excretion of the antibiotic, with rates of renal clearance averaging 425 ml/min per 1.73 m2 in the patients with CF and 362 ml/min per 1.73 m2 in the normal subjects. No differences were found in volumes of distribution and metabolic clearance rates of methicillin or in rates of creatinine clearance between the two groups of subjects. These data support previous findings with dicloxacillin which show that patients with CF exhibit unusually rapid, active tubular secretion of certain penicillins that may necessitate use of larger doses of these drugs in treatment of infections.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404369     DOI: 10.1093/infdis/135.5.828

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

Review 1.  Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.

Authors:  D P Greenberg; H R Stutman
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 2.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 3.  Drug disposition in cystic fibrosis.

Authors:  E Rey; J M Tréluyer; G Pons
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

4.  Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.

Authors:  A Hedman; G Alván; B Strandvik; A Arvidsson
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

5.  Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.

Authors:  A Hedman; Y Adan-Abdi; G Alvan; B Strandvik; A Arvidsson
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

6.  The tubular excretion of benzylpenicillin in patients with cystic fibrosis.

Authors:  J W Bins; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

Review 7.  Cystic fibrosis--a challenging masquerader.

Authors:  B C Hilman
Journal:  Clin Rev Allergy       Date:  1983-03

Review 8.  Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.

Authors:  D J Touw; A A Vinks; J W Mouton; A M Horrevorts
Journal:  Clin Pharmacokinet       Date:  1998-12       Impact factor: 6.447

9.  The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.

Authors:  J A Ziemniak; B M Assael; R Padoan; J J Schentag
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Pharmacokinetics of netilmicin in children with and without cystic fibrosis.

Authors:  H Michalsen; T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.